• By ICR Secretariat
  • Posted Thursday, July 8, 2021

U.K. Supreme Court rejects NHS claim of €220M financial loss in Servier patent lawsuit

https://www.fiercepharma.com/pharma/u-k-supreme-court-rejects-nhs-claim-eu220m-financial-loss-servier-ip-lawsuit

In the culmination of a 10-year case, the U.K. Supreme Court has ruled in favor of Servier Laboratories in its defense against England’s National Health Service over a patent on cardio drug Coversyl.